Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losmapimod in Major Depressive Disorder with Inflammatory Symptoms
NCT00569062Phase 2Terminated
- Sponsor
- GSK
- Start
- Sep 2007
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of losmapimod in major depressive disorder (MDD), sponsored by GSK. Started Sep 2007; status: terminated.
02
Drugs
losmapimod
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00569062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00569062.